Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
46,000
-1,000 (-2.13%)
At close: May 21, 2026
Market Cap385.58B +11.0%
Revenue (ttm)16.48B +72.7%
Net Income-311.08M
EPS-38.27
Shares Out8.20M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume47,499
Average Volume67,656
Open47,600
Previous Close47,000
Day's Range45,450 - 49,250
52-Week Range39,300 - 101,000
Betan/a
RSI26.87
Earnings DateMar 27, 2026

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

Financial Performance

Financial Statements